Surmodics, Inc. in brief
Surmodics, Inc. is an unlisted company in the Medical Devices industry, based in Minnesota, USA. It was founded in 1979. In the year to Sep 2021 it had sales of $105 M and a net profit of $4 M, about 4 cents of profit for every dollar of sales.
Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.
About Surmodics, Inc.
SurModics is the leader in surface modification technologies for intravascular medical devices and a provider of chemical components for in vitro diagnostic (IVD) tests and microarrays. The headquarters is in USA.
Surmodics company annual revenue was 99 million USD and annual net loss was -27 as on Sep-2022.
Surmodics, Inc. timeline
- 1979
- 🏁· approximateFounded
- 1998
- 🔔· approximateInitial public offering on Nasdaq
Events of Surmodics, Inc. from the company record. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
More about Surmodics, Inc.
- Acquisitions and changes
- No longer listed: ticker SRDX is not in the SEC's, the US exchanges' or FINRA's lists of traded securities (checked 14 November 2026).
Market cap history
World rank over time
Rank in USA: #2,400 (Jan 2020) · #2,614 (Jan 2021) · #2,973 (Jan 2022) · #2,682 (Dec 2022) · #2,780 (Jul 2023) · #2,566 (Jan 2024)
Key ratios
- P/E ratio
- —
- Price / sales
- —
- Price / book
- —
- Free cash flow yield
- —
- Net margin
- 3.8%
- Operating margin
- —
- Return on equity
- 2.9%
- Liabilities / assets
- 27.8%
Annual results
- Revenue
- $105 M
- Operating income
- —
- Net income
- $4 M
Sep-2021 ending year
Balance sheet
- Total assets
- $194 M
- Total liabilities
- $54 M
- Total equity
- $140 M
Sep-2021 ending year
Markets and events: Surmodics, Inc.#
Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.
Trading halts
- 2025-11-19 00:50 UTC, code D, resumed 05:00 UTC
- 2025-11-10 19:45 UTC, code T3, resumed 12:00 UTC
Fails to deliver
- : 104,277 shares at $42.98
- : 8,640 shares at $42.83
- : 6,523 shares at $41.41
- : 699 shares at $40.94
- : 46 shares at $28.32
Source: FINRA, SEC EDGAR (8-K, S-1/F-1, 424B4, XBRL, fails-to-deliver), Nasdaq Trader, Wikipedia index change tables
H-1B hiring at Surmodics, Inc.#
1 labor condition applications certified in fiscal 2023 for 1 positions, at a median wage of $78 K a year.
| Job title | Positions | Median wage offered |
|---|---|---|
| Regulatory Affairs AssociateRegulatory Affairs Specialists | 1 | $78 K |
Where: Eden Prairie, MN 1
| Fiscal year | Certified | Positions | Median wage | Filed |
|---|---|---|---|---|
| FY2023 | 1 | 1 | $78 K | 1 |
| FY2020 | 1 | 1 | $78 K | 1 |
Source: US Department of Labor, LCA disclosure data. An application is not a visa: USCIS decides each petition later, and the yearly lottery limits new H-1B visas. Filed as Surmodics, Inc.
How Surmodics, Inc. compares in Medical Devices
- Revenue$105 M · higher than 42% of 155
- Net margin3.8% · higher than 61% of 144
Peer comparison · Medical Devices
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| Surmodics, Inc.🇺🇸 | $487 M | — | 3.8% | — |
| Abbott Laboratories🇺🇸 | $181.1 B | 38.5× | 9.8% | +5.7% |
| Medtronic plc🇺🇸 | $121.2 B | 23.2× | 13.9% | +8.4% |
| Stryker Corporation🇺🇸 | $116.5 B | 32.2× | 13.8% | +11.2% |
| Boston Scientific Corporation🇺🇸 | $66.2 B | 18.9× | 16.6% | +19.9% |
| Edwards Lifesciences Corporation🇺🇸 | $52.8 B | 51.7× | 15.3% | +11.6% |
| Shenzhen Mindray Bio-Medical Electronics Co., Ltd.🇨🇳 | $27.8 B | 23.6× | 24.4% | — |
| STERIS plc🇮🇪 | $20.4 B | 24.6× | 13.4% | +8.7% |
| Zimmer Biomet Holdings, Inc.🇺🇸 | $18.2 B | 23.8× | 8.9% | +7.2% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Questions people ask
Compare head to head
Similar companies by size and industry
- Abbott Laboratories$181.1 B
- Medtronic plc$121.2 B
- Stryker Corporation$116.5 B
- Boston Scientific Corporation$66.2 B
- Edwards Lifesciences Corporation$52.8 B
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd.$27.8 B
Sources and freshness
- Market cap:
- Jan 5, 2024 (last known)
- Annual results:
- Sep-2021 ending year
- Balance sheet:
- Sep-2021 ending year
- Profile updated:
- Nov 14, 2026
Figures from value.today research.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at Surmodics, Inc.? Verify and update this profile — free
Show Surmodics, Inc.'s ranking or a chart on your website Get the badge
The badge updates itself as the ranking changes.